Spero Therapeutics (SPRO) Net Cash Flow (QoQ) (2017 - 2026)
Spero Therapeutics (SPRO) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Spero Therapeutics |
129.74 Mn |
73.61 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
289.97% |
| Dec 31, 2025 |
-147.93% |
| Sep 30, 2025 |
198.47% |
| Jun 30, 2025 |
-342.10% |
| Mar 31, 2025 |
82.90% |
| Dec 31, 2024 |
-283.35% |
| Sep 30, 2024 |
168.09% |
| Jun 30, 2024 |
-415.66% |
| Mar 31, 2024 |
133.95% |
| Dec 31, 2023 |
-208.41% |
| Sep 30, 2023 |
186.92% |
| Jun 30, 2023 |
-44.43% |
| Mar 31, 2023 |
-121.91% |
| Dec 31, 2022 |
1,062.76% |
| Sep 30, 2022 |
118.89% |
| Jun 30, 2022 |
34.01% |
| Mar 31, 2022 |
-14,617.45% |
| Dec 31, 2021 |
-100.67% |
| Sep 30, 2021 |
853.59% |
| Jun 30, 2021 |
32.90% |
